# EMTRICITABINE
> **ANDA091168** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-07-02
## Drug
- **FDA Application Number:** ANDA091168
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMTRICITABINE
- **Generic name:** EMTRICITABINE
- **Active ingredients:** EMTRICITABINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2018-07-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091168)
---
*AI Analytics · CC0 1.0*